# IRONWOOD PHARMACEUTICALS INC (IRWD) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from IRONWOOD PHARMACEUTICALS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/IRWD/mda/fy2025/): filed 2026-02-26; accession 0001104659-26-020489 (https://www.sec.gov/Archives/edgar/data/1446847/000110465926020489/irwd-20251231x10k.htm); latest 10-K
- [FY 2024 MD&A](/company/IRWD/mda/fy2024/): filed 2025-03-31; accession 0001558370-25-004072 (https://www.sec.gov/Archives/edgar/data/1446847/000155837025004072/irwd-20241231x10k.htm)
- [FY 2023 MD&A](/company/IRWD/mda/fy2023/): filed 2024-02-16; accession 0001558370-24-001275 (https://www.sec.gov/Archives/edgar/data/1446847/000155837024001275/irwd-20231231x10k.htm)
- [FY 2022 MD&A](/company/IRWD/mda/fy2022/): filed 2023-02-16; accession 0001558370-23-001462 (https://www.sec.gov/Archives/edgar/data/1446847/000155837023001462/irwd-20221231x10k.htm)
- [FY 2021 MD&A](/company/IRWD/mda/fy2021/): filed 2022-02-18; accession 0001558370-22-001368 (https://www.sec.gov/Archives/edgar/data/1446847/000155837022001368/irwd-20211231x10k.htm)

Back to /company/IRWD/